红细胞生成素受体(EPOR)重组蛋白
Recombinant Erythropoietin Receptor (EPOR)
EPO-R
- 编号RPA027Ra01
- 物种Rattus norvegicus (Rat,大鼠) 相同的名称,不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位细胞膜
- 预测分子量18.2kDa
- 实际分子量21kDa(差异分析请参阅说明书)
- 片段与标签Leu314~Tyr467 with N-terminal His Tag
- 缓冲液成份20mM Tris, 150mM NaCl缓冲液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性状冻干粉
- 纯度> 90%
- 等电点4.6
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1051 ¥ 2628 ¥ 5256 ¥ 15768 ¥ 39420
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Rattus norvegicus (Rat,大鼠) | 应用(仅供研究使用,不用于临床诊断!) |
RPA027Ra01 | 红细胞生成素受体(EPOR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA027Ra01 | 红细胞生成素受体(EPOR)多克隆抗体 | WB; IHC; ICC; IP. |
LAA027Ra71 | 红细胞生成素受体(EPOR)多克隆抗体(生物素标记) | WB; IHC; ICC. |
MAA027Ra21 | 红细胞生成素受体(EPOR)单克隆抗体 | WB; IHC; ICC; IP. |
MAA027Ra22 | 红细胞生成素受体(EPOR)单克隆抗体 | WB; IHC; ICC; IP. |
SEA027Ra | 红细胞生成素受体(EPOR)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA027Ra | 红细胞生成素受体(EPOR)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
J Appl Physiol (1985). | Decreased plasma soluble erythropoietin receptor in high-altitude excessive erythrocytosis and Chronic Mountain Sickness [Pubmed:25324511] |
J Appl Physiol | Plasma soluble erythropoietin receptor is decreased during sleep in Andean highlanders with Chronic Mountain Sickness [Pubmed:27125843] |
FASEB JOURNAL | High-altitude hypoxia decreases plasma erythropoietin soluble receptor (sEpoR) concentration in humans [] |
high altitude medicine & biology | High-Altitude Hypoxia Decreases Plasma Erythropoietin Soluble Receptor Concentration in Lowlanders [Pubmed: 31977247] |
Physiology Reports | Effect of exercise training in rats exposed to chronic hypoxia: Application for Monge's disease [33904648] |
留言咨询